Pulmonary Vascular Disease News

In a new study, initial combination therapy for pulmonary arterial hypertension improved functional class and exercise capacity after 6 months, but low-risk status was achieved or maintained in only a minority of patients.

New data from the HoT-PE trial further support a strategy of early discharge and home oral anticoagulation with rivaroxaban in selected patients with low-risk pulmonary embolism.

Pulmonary hypertension was associated with longer hospitalization and lower odds of routine discharge among patients with acute ischemic stroke, researchers reported.

During the menstrual cycle, premenopausal women with pulmonary arterial hypertension experience fluctuations in markers of cardiopulmonary function that may be driven by estradiol and dehydroepiandrosterone sulfate.

Use of an abridged version of the REVEAL 2.0 risk calculator, REVEAL Lite 2, provided a simplified method of mortality risk assessment for patients with pulmonary arterial hypertension, researchers reported in Chest.

The U.S. Pulmonary Hypertension Scientific Registry provides novel insights on patient characteristics, diagnosis delays and treatment trends in adults with pulmonary arterial hypertension.

New data suggest that the decreasing trend of pulmonary embolism-related mortality in North America slowed after 2006 among young and middle-aged adults in the United States and plateaued among older adults.

The Healio editors have compiled a list of the most-read pulmonary arterial hypertension news published in 2020.

Using a diagnostic algorithm, pulmonary embolism was detected in nearly 6% of patients hospitalized with COPD with acute worsening of respiratory symptoms, according to a study published in JAMA.

In a national private health care database, age, male sex and comorbidities increased risk for death in patients hospitalized with COVID-19, according to data presented at the virtual American Heart Association Scientific Sessions.